Ryan A.C.
Senior Vice President, Corporate Affairs
Replay available
Revolution Medicines, Inc. (RVMD) Q1 2026 Earnings Call
Revolution Medicines, Inc. (NASDAQ: RVMD) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Mark Goldsmith
Chairman and Chief Executive Officer
Dr. Alan Sandler
Chief Development Officer
Jack Anders
Chief Financial Officer
Dr. Steve Kelsey
President, Research and Development
Dr. Wei Lin
Chief Medical Officer
Anthony Mancini
Chief Global Commercialization Officer
Corey Kasimov
Evercore ISI Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Revolution Medicines, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.056 Good day, and thank you for standing by. Welcome to the Revolution Medicine's Q1 00:00:05.056 -- 00:00:10.160 2026 earnings call. At this time, participants are in a listen-only 00:00:10.160 -- 00:00:14.524 mode. After the speaker's presentation, there will be a question and answer session. 00:00:14.524 -- 00:00:20.289 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:20.289 -- 00:00:24.213 You will then hear an automated message advising you your hand is raised. 00:00:24.213 -- 00:00:27.858 To withdraw your question, please press star 1 1 again. 00:00:27.858 -- 00:00:31.444 Please be advised that today's conference is being recorded. 00:00:31.444 -- 00:00:37.353 I would now like to hand it over to Ryan A.C., Senior VP of Corporate Affairs. 00:00:37.353 -- 00:00:39.336 Ryan, you have the floor. 00:00:39.336 -- 00:00:43.964 Thank you, operator, and welcome everyone to the first quarter 2026 earnings call. 00:00:43.964 -- 00:00:48.030 Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicine's Chairman and 00:00:48.030 -- 00:00:53.218 Chief Executive Officer, Dr. Alan Sandler, our Chief Development Officer, and 00:00:53.218 -- 00:00:56.249 Jack Anders, our Chief Financial Officer. Dr. 00:00:56.249 -- 00:01:01.415 Steve Kelsey, our president of R&D, Dr. Wei Lin, our chief medical officer, 00:01:01.415 -- 00:01:05.539 and Anthony Mancini, our chief global commercialization officer, will join us for the 00:01:05.539 -- 00:01:08.722 Q&A portion of today's call. 00:01:08.722 -- 00:01:11.725 We would like to inform you that certain statements we made during this call will be 00:01:11.725 -- 00:01:16.290 forward-looking because such statements deal with future events and are subject ...